Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Type-2 Diabetes Semaglutide helps manage blood sugar levels in individuals with Type 2 diabetes by stimulating insulin release when blood sugar rises and reducing the amount of glucose produced by the liver
Traditional weight management methods often fail because of intense hunger or emotional eating disorders
Its dual GLP-1 and GIP receptor activation produced a 20.9% average body weight reduction at 72 weeks in the SURMOUNT-1 trial, and more recent SURMOUNT-5 head-to-head data confirmed its superiority over Semaglutide
This is particularly useful for: Men who feel the dose "wearing off" before their next injection day
508,509,510,511 Additionally, GLP-1 mitigates liver inflammation and fibrosis by inhibiting the NF-B pathway, reducing the release of pro-inflammatory cytokines such as TNF- and IL-6, and thus suppressing inflammatory pathways
